BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Shen OY, Chen YF, Xu HT, Lee CW. The Efficacy of Naïve versus Modified Mesenchymal Stem Cells in Improving Muscle Function in Duchenne Muscular Dystrophy: A Systematic Review. Biomedicines 2021;9:1097. [PMID: 34572283 DOI: 10.3390/biomedicines9091097] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Namiot ED, Niemi JVL, Chubarev VN, Tarasov VV, Schiöth HB. Stem Cells in Clinical Trials on Neurological Disorders: Trends in Stem Cells Origins, Indications, and Status of the Clinical Trials. IJMS 2022;23:11453. [DOI: 10.3390/ijms231911453] [Reference Citation Analysis]
2 Matsuzaka Y, Hirai Y, Hashido K, Okada T. Therapeutic Application of Extracellular Vesicles-Capsulated Adeno-Associated Virus Vector via nSMase2/Smpd3, Satellite, and Immune Cells in Duchenne Muscular Dystrophy. Int J Mol Sci 2022;23:1551. [PMID: 35163475 DOI: 10.3390/ijms23031551] [Reference Citation Analysis]
3 Farini A. Special Issue: Pathophysiology and Therapeutic Perspectives in DMD: The Well-Defined Role of the Immune System. Biomedicines 2021;9:1911. [PMID: 34944724 DOI: 10.3390/biomedicines9121911] [Reference Citation Analysis]
4 Yudintceva N, Lomert E, Mikhailova N, Tolkunova E, Agadzhanian N, Samochernych K, Multhoff G, Timin G, Ryzhov V, Deriglazov V, Mazur A, Shevtsov M. Targeting Brain Tumors with Mesenchymal Stem Cells in the Experimental Model of the Orthotopic Glioblastoma in Rats. Biomedicines 2021;9:1592. [PMID: 34829821 DOI: 10.3390/biomedicines9111592] [Reference Citation Analysis]